Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | The role of hormonal changes in modulating MS in pregnant women

Kristen Krysko, MD, University of California San Francisco, San Francisco, CA, comments on how pregnancy can reduce the severity of multiple sclerosis. Hormonal fluctuations that occur during pregnancy such as changes in estriol and progesterone levels have found to have a protective effect in mothers against MS. Whilst the exact hormone causing this is unknown, breastfeeding additionally has a similar modulating effect in women. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.


Dr. Krysko reports the following disclosures:
Consultant: Normative Inc.;Biogen; Roche; EMD Serono; Novartis
Scientific Advisory or Data Safety Monitoring board: Novartis
The institution of Dr. Krysko has received research support from Biogen Idec. & National MS Society.